JSP191 (briquilimab) in Subjects with LR-MDS

Clinical trial NCT05903274 · TERMINATED

Trial details

NCT number: NCT05903274
Sponsor: Jasper Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Lower-risk Myelodysplastic Syndrome

Start date: 2023-06-19
Primary completion: 2024-10-21
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.